1. Serum‐derived bovine immunoglobulin treatment in COVID‐19 is associated with faster resolution of symptoms: A randomized pilot clinical trial.
- Author
-
Utay, Netanya S., Güerri‐Fernández, Roberto, Gharakhanian, Shahin, Asmuth, David M., Contreras, Moises, Kunkler, Charlotte, Detzel, Christopher J., and Warner, Christopher D.
- Subjects
DRUG interactions ,CLINICAL trials ,DISEASE management ,MEDICAL supplies ,ODDS ratio - Abstract
Effective treatment to prevent hospitalization and death in people with COVID‐19 exists, but people still need interventions that alleviate symptoms without drug interactions. Oral serum‐derived bovine immunoglobulins (SBI) may reduce symptoms and time‐to‐improvement in people with mild‐to‐moderate COVID‐19. In this randomized, open‐label, single‐site study, participants with mild‐to‐moderate COVID‐19 received SBI 5.0 g bis in die (BID) + Standard of Care (SOC) or SOC alone (2:1) for 2 weeks. After 2 weeks, 78.8% of hospitalized participants on SBI + SOC improved by World Health Organization (WHO) scale of ≥3 compared to 61.1% on SOC alone (odds ratio: OR = 2.4; p = 0.0663), with older participants (>57 years) showing more significant differences between the arms (OR = 6.1; p = 0.0109). Further, more participants on SBI + SOC reported absence of COVID‐19 symptoms at Week 2 (74.2%) compared to SOC alone (43.6%; OR = 3.7; p = 0.0031), most notably the absence of dyspnea on exertion (OR = 4.4; p = 0.0047), with women exhibiting the most significant eradication of all symptoms (OR = 5.8; p = 0.0080). No difference in change of IL‐6 between arms was observed. Overall, participants with mild‐to‐moderate COVID‐19 on SBI + SOC had a shorter time‐to‐recovery than on SOC alone, with a significantly higher rate of complete resolution of symptoms. Dyspnea on exertion was the symptom most significantly impacted. For people with mild‐to‐moderate COVID‐19, oral SBI could be a safe and effective intervention, devoid of drug interactions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF